Panax Ginseng (Asian Ginseng) trials recruiting now

2 registrations that name panax Ginseng as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Filter 2 registrations

Status

1US sites across 1 state

All 2 registrations

RecruitingNCT07729943

A Trial to Study the Effects of Ginseng and Cordyceps on Aerobic Capacity, Lactate Kinetics, and Nitric Oxide

  • No phase
  • Applied Food Sciences Inc.
  • About 75 people
  • Started Mar 15, 2026

In plain words A study of panax Ginseng in people 40 to 65, run by Applied Food Sciences Inc.. It plans to enroll about 75 people at 1 US site.

Who it lists and where

Who the trial lists, as registered

Lists people 40 to 65; healthy volunteers accepted. Conditions: Healthy Subjects With Low Energy Levels.

  • Provide voluntary signed and dated informed consent.
  • Be in good health and able to participate in cognitive performance testing as determined by assessment, medical history, and routine blood chemistries.
  • Between the of 40 and 65 years of age (inclusive).
  • Body Mass Index of 18.5-34.9 (inclusive).

7 more inclusion criteria and the exclusion criteria are on the listing.

What it tests, as registered

Panax ginseng; Cordycep Militaris; Placebo

Registered summary

This study is a double-blind, randomized, parallel group, three-arm, placebo-controlled trial of seventy-five (75) apparently healthy male and female participants to be recruited at a single investigational center in Northeast Ohio (i.e., The Center for Applied Health Sciences). The study will assess the potential benefits of four weeks of supplementation with 300 mg Ginseng or 1 gram Cordyceps Militaris (vs. placebo). Participants will attend 3 study visits. The full summary is on the listing.

Where, as registered

1 US site in 1 state.

RecruitingNCT03775837

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

  • No phase
  • Pusan National University Yangsan Hospital
  • About 60 people
  • Started Dec 1, 2018

In plain words A study of panax Ginseng in people 19 to 75, run by Pusan National University Yangsan Hospital. It plans to enroll about 60 people at 1 site, none in the US.

Who it lists and where

Who the trial lists, as registered

Lists people 19 to 75; healthy volunteers accepted. Conditions: Liver Diseases.

  • ALT ranging from upper limit of reference to three times of upper limit

The exclusion criteria are on the listing.

What it tests, as registered

Panax Ginseng C.A. Mey Extract group; Placebo group

Registered summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.

Where, as registered

No US site; South Korea (1).

ClinicalTrials.gov lists 35 open registrations for this search, including ones where panax Ginseng is not a study arm or that are past the 2 we keep. Search them on ClinicalTrials.gov (opens in new tab).

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.